Tag: Infinity Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Infinity Pharmaceuticals

Infinity Pharmaceuticals (NASDAQ:INFI) Lowered to Hold at Zacks Investment Research

Added to Collection on: 2018-10-16 02:45:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Infinity Pharmaceuticals (INFI) Upgraded to Hold by ValuEngine

Added to Collection on: 2019-02-28 08:11:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Infinity Pharmaceuticals (INFI) Downgraded by ValuEngine to Sell

Added to Collection on: 2019-05-10 02:56:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Infinity Pharmaceuticals (INFI) Raised to Hold at ValuEngine

Added to Collection on: 2019-06-03 11:22:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Infinity Pharmaceuticals (NASDAQ:INFI) Stock Rating Upgraded by ValuEngine

Added to Collection on: 2019-08-01 19:15:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Infinity Pharmaceuticals (NASDAQ:INFI) Earns Buy Rating from Analysts at B. Riley

Added to Collection on: 2019-12-12 08:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Infinity Pharmaceuticals (NASDAQ:INFI) Upgraded at JPMorgan Chase & Co.

Added to Collection on: 2021-02-05 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
B. Riley Raises Infinity Pharmaceuticals (NASDAQ:INFI) Price Target to $8.00

Added to Collection on: 2021-02-05 12:17:34

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
DLA Piper advises Piper Sandler & Co. as sole book-running manager in connection with US$92 ...

Added to Collection on: 2021-03-02 22:18:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Infinity Pharmaceuticals (NASDAQ:INFI) Earns Buy Rating from Analysts at Truist

Added to Collection on: 2021-03-17 13:16:37

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Book a Demo